Expression of Yes-associated protein in common solid tumors

Angela A. Steinhardt, Mariana F. Gayyed, Alison P. Klein, Jixin Dong, Anirban Maitra, Duojia Pan, Elizabeth A. Montgomery, Robert A. Anders

Research output: Contribution to journalArticle

361 Citations (Scopus)

Abstract

The Hippo signaling pathway is a highly conserved potent regulator of cell growth, division, and apoptosis. Yes-associated protein (YAP), the nuclear effector of the Hippo pathway, is a highly conserved component of this pathway in mammalian systems. In humans, amplification of the chromosome region containing the YAP gene (11q22) has been reported in several tumor types. This study was performed to determine if YAP expression was present in 4 common types of malignant tumors that have the highest lifetime risk of causing cancer death among men and women in the United States. The YAP expression intensity and distribution were evaluated in normal tissues and compared to the most frequently occurring malignant tumors in these tissues (colonic adenocarcinoma, lung adenocarcinoma, ovarian serous cystadenocarcinoma, and ductal carcinoma of the breast). For each tissue, the nuclear and cytoplasmic YAP expression intensity was scored as negative, low, or high. We found focal expression of YAP in the progenitor and reparative cellular compartments of normal tissue. In contrast, there was strong and diffuse nuclear and cytoplasmic YAP expression in colonic adenocarcinoma, lung adenocarcinoma, and ovarian serous cystadenocarcinoma. We concluded that the potent Hippo growth regulatory pathway shows markedly different expression patterns in normal tissues of the colon, lung, and ovary compared to the 3 common malignant tumor types we examined in these tissues. Our findings suggest that activation of the Hippo signaling pathway may occur through YAP as part of cell proliferation in normal tissue homeostasis and also might be a frequently activated oncogenic pathway in 3 common malignant tumor types.

Original languageEnglish (US)
Pages (from-to)1582-1589
Number of pages8
JournalHuman Pathology
Volume39
Issue number11
DOIs
StatePublished - Nov 1 2008
Externally publishedYes

Fingerprint

Serous Cystadenocarcinoma
Neoplasms
Proteins
Carcinoma, Ductal, Breast
Human Chromosomes
Growth
Nuclear Proteins
Cell Division
Ovary
Colon
Homeostasis
Cell Proliferation
Apoptosis
Lung
Adenocarcinoma of lung

Keywords

  • Hippo
  • Immunohistochemistry
  • Tumorigenesis
  • Yes-associated protein

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Steinhardt, A. A., Gayyed, M. F., Klein, A. P., Dong, J., Maitra, A., Pan, D., ... Anders, R. A. (2008). Expression of Yes-associated protein in common solid tumors. Human Pathology, 39(11), 1582-1589. https://doi.org/10.1016/j.humpath.2008.04.012

Expression of Yes-associated protein in common solid tumors. / Steinhardt, Angela A.; Gayyed, Mariana F.; Klein, Alison P.; Dong, Jixin; Maitra, Anirban; Pan, Duojia; Montgomery, Elizabeth A.; Anders, Robert A.

In: Human Pathology, Vol. 39, No. 11, 01.11.2008, p. 1582-1589.

Research output: Contribution to journalArticle

Steinhardt, AA, Gayyed, MF, Klein, AP, Dong, J, Maitra, A, Pan, D, Montgomery, EA & Anders, RA 2008, 'Expression of Yes-associated protein in common solid tumors', Human Pathology, vol. 39, no. 11, pp. 1582-1589. https://doi.org/10.1016/j.humpath.2008.04.012
Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D et al. Expression of Yes-associated protein in common solid tumors. Human Pathology. 2008 Nov 1;39(11):1582-1589. https://doi.org/10.1016/j.humpath.2008.04.012
Steinhardt, Angela A. ; Gayyed, Mariana F. ; Klein, Alison P. ; Dong, Jixin ; Maitra, Anirban ; Pan, Duojia ; Montgomery, Elizabeth A. ; Anders, Robert A. / Expression of Yes-associated protein in common solid tumors. In: Human Pathology. 2008 ; Vol. 39, No. 11. pp. 1582-1589.
@article{3d41bbd7c50b4d2ca95349237d0d8499,
title = "Expression of Yes-associated protein in common solid tumors",
abstract = "The Hippo signaling pathway is a highly conserved potent regulator of cell growth, division, and apoptosis. Yes-associated protein (YAP), the nuclear effector of the Hippo pathway, is a highly conserved component of this pathway in mammalian systems. In humans, amplification of the chromosome region containing the YAP gene (11q22) has been reported in several tumor types. This study was performed to determine if YAP expression was present in 4 common types of malignant tumors that have the highest lifetime risk of causing cancer death among men and women in the United States. The YAP expression intensity and distribution were evaluated in normal tissues and compared to the most frequently occurring malignant tumors in these tissues (colonic adenocarcinoma, lung adenocarcinoma, ovarian serous cystadenocarcinoma, and ductal carcinoma of the breast). For each tissue, the nuclear and cytoplasmic YAP expression intensity was scored as negative, low, or high. We found focal expression of YAP in the progenitor and reparative cellular compartments of normal tissue. In contrast, there was strong and diffuse nuclear and cytoplasmic YAP expression in colonic adenocarcinoma, lung adenocarcinoma, and ovarian serous cystadenocarcinoma. We concluded that the potent Hippo growth regulatory pathway shows markedly different expression patterns in normal tissues of the colon, lung, and ovary compared to the 3 common malignant tumor types we examined in these tissues. Our findings suggest that activation of the Hippo signaling pathway may occur through YAP as part of cell proliferation in normal tissue homeostasis and also might be a frequently activated oncogenic pathway in 3 common malignant tumor types.",
keywords = "Hippo, Immunohistochemistry, Tumorigenesis, Yes-associated protein",
author = "Steinhardt, {Angela A.} and Gayyed, {Mariana F.} and Klein, {Alison P.} and Jixin Dong and Anirban Maitra and Duojia Pan and Montgomery, {Elizabeth A.} and Anders, {Robert A.}",
year = "2008",
month = "11",
day = "1",
doi = "10.1016/j.humpath.2008.04.012",
language = "English (US)",
volume = "39",
pages = "1582--1589",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Expression of Yes-associated protein in common solid tumors

AU - Steinhardt, Angela A.

AU - Gayyed, Mariana F.

AU - Klein, Alison P.

AU - Dong, Jixin

AU - Maitra, Anirban

AU - Pan, Duojia

AU - Montgomery, Elizabeth A.

AU - Anders, Robert A.

PY - 2008/11/1

Y1 - 2008/11/1

N2 - The Hippo signaling pathway is a highly conserved potent regulator of cell growth, division, and apoptosis. Yes-associated protein (YAP), the nuclear effector of the Hippo pathway, is a highly conserved component of this pathway in mammalian systems. In humans, amplification of the chromosome region containing the YAP gene (11q22) has been reported in several tumor types. This study was performed to determine if YAP expression was present in 4 common types of malignant tumors that have the highest lifetime risk of causing cancer death among men and women in the United States. The YAP expression intensity and distribution were evaluated in normal tissues and compared to the most frequently occurring malignant tumors in these tissues (colonic adenocarcinoma, lung adenocarcinoma, ovarian serous cystadenocarcinoma, and ductal carcinoma of the breast). For each tissue, the nuclear and cytoplasmic YAP expression intensity was scored as negative, low, or high. We found focal expression of YAP in the progenitor and reparative cellular compartments of normal tissue. In contrast, there was strong and diffuse nuclear and cytoplasmic YAP expression in colonic adenocarcinoma, lung adenocarcinoma, and ovarian serous cystadenocarcinoma. We concluded that the potent Hippo growth regulatory pathway shows markedly different expression patterns in normal tissues of the colon, lung, and ovary compared to the 3 common malignant tumor types we examined in these tissues. Our findings suggest that activation of the Hippo signaling pathway may occur through YAP as part of cell proliferation in normal tissue homeostasis and also might be a frequently activated oncogenic pathway in 3 common malignant tumor types.

AB - The Hippo signaling pathway is a highly conserved potent regulator of cell growth, division, and apoptosis. Yes-associated protein (YAP), the nuclear effector of the Hippo pathway, is a highly conserved component of this pathway in mammalian systems. In humans, amplification of the chromosome region containing the YAP gene (11q22) has been reported in several tumor types. This study was performed to determine if YAP expression was present in 4 common types of malignant tumors that have the highest lifetime risk of causing cancer death among men and women in the United States. The YAP expression intensity and distribution were evaluated in normal tissues and compared to the most frequently occurring malignant tumors in these tissues (colonic adenocarcinoma, lung adenocarcinoma, ovarian serous cystadenocarcinoma, and ductal carcinoma of the breast). For each tissue, the nuclear and cytoplasmic YAP expression intensity was scored as negative, low, or high. We found focal expression of YAP in the progenitor and reparative cellular compartments of normal tissue. In contrast, there was strong and diffuse nuclear and cytoplasmic YAP expression in colonic adenocarcinoma, lung adenocarcinoma, and ovarian serous cystadenocarcinoma. We concluded that the potent Hippo growth regulatory pathway shows markedly different expression patterns in normal tissues of the colon, lung, and ovary compared to the 3 common malignant tumor types we examined in these tissues. Our findings suggest that activation of the Hippo signaling pathway may occur through YAP as part of cell proliferation in normal tissue homeostasis and also might be a frequently activated oncogenic pathway in 3 common malignant tumor types.

KW - Hippo

KW - Immunohistochemistry

KW - Tumorigenesis

KW - Yes-associated protein

UR - http://www.scopus.com/inward/record.url?scp=53849087493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53849087493&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2008.04.012

DO - 10.1016/j.humpath.2008.04.012

M3 - Article

VL - 39

SP - 1582

EP - 1589

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 11

ER -